Sickle Cell Anemia at Penn Medicine: What's New and What's Next
About this episode
Drs Nadia Dawn Ali and Scott Peslak discuss the pathology of sickle cell disease and recent treatment advancements.
Drs Nadia Dawn Ali and Scott Peslak examine the pathology of sickle cell disease, its variable effects, and recent advances in treatment, including stem cell therapies and other new FDA-approved regimens for the disease.
More episodes of Penn Medicine Physician Interviews
- Advancing Meningioma Care: A Multidisciplinary Approach at Penn Medicine
- Proton Therapy As De-Intensification Strategy For HPV+ Head and Neck Cancers
- Muscle-Sparing Direct Anterior Approach To Total Hip Arthroplasty
- T Cell Lymphomas—Navigating The Journey From Diagnosis To Treatment And Beyond
- Gynecologic oncology: the known, the unknown, and the promising
- The Center for Precision Surgery Marks 10 Years of Illuminating Cancer Cells in Practice and Research
Explore listener stats, chart rankings, contacts and more on the Penn Medicine Physician Interviews podcast page.